According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031.
In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt